881 / 1851
TMZ alone is not inferior to RT alone in the
treatment of Elderly GBM.
MGMT promoter methylation seems to be a useful
biomarker and could aid decision-making
Elderly patients: TMZ vs RT (NORDIC and NOA-08)
Malmstrom A. et al. Lancet Oncol 2012;13
Wick W. et al. Lancet Oncol 2012;13
60 Gy